Indicator assays for polycyclic aromatic hydrocarbon-induced genotoxicity

The Carcinogenic Effects of Polycyclic Aromatic Hydrocarbons

Volumn , Issue , 2005, Pages 283-314

  Glatt, Hansruedi ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967702683     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781860949333_0008     Document Type: Chapter

References (159)

1. Kennaway EL and Hieger I (1930) Carcinogenic substances and their fluorescence spectra. Br. Med. J. 1: 1044-1046.
2. Cook JW, Hewett CL and Hieger I (1933) The isolation of a cancer-producing hydrocarbon from coal tar: parts I, II, and III. J. Chem. Soc. 395-405.
3. Katsanakis KD, Gorgoulis V, Papavassiliou AG and Zoumpourlis VK (2002) The progression in the mouse skin carcinogenesis model correlates with ERK1/2 signaling. Mol. Med. 8: 624-637.
4. Sugiyama T, Osaka M, Koami K, Maeda S and Ueda N (2002) 7,12-DMBA- induced rat leukemia: a review with insights into future research. Leuk Res. 26: 1053-1068.
5. Shan L, He M, Yu M, Qiu C, Lee NH, Liu ET and Snyderwine EG (2000) cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1 -methyl-6-phenylimidazo[4,5-b]pyridine and 7,12- dimethylbenz[a]anthracene. Carcinogenesis 23: 1561-1568.
6. Wessner LL, Fan M, Schaeffer DO, McEntee MF and Miller MS (1996) Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene. Carcinogenesis 17:1519-1526.
7. Kupfer R, Dwyer-Nield LD, Malkinson AM and Thompson JA (2002) Lung toxicity and tumor promotion by hydroxylated derivatives of 2,6-di-tert- butyl-4-methylphenol (BHT) and 2-tert-butyl-4-methyl-6-iso-propylphenol: correlation with quinone methide reactivity. Chem. Res. Toxicol. 15: 1106-1112.
8. Baral RN and Maity P (1992) Induction of colorectal cancer in rats by 20- methylcholanthrene. Cancer Lett. 61: 177-183.
9. Boveri T (1929) The Origin of Malignant Tumors. Williams and Wilkins Co., Baltimore, MD, USA. (Translation of the German original published in 1914: Zur Frage der Entstehung maligner Tumore. Gustav Fischer, Jena, Germany.).
10. Loeb KR and Loeb LA (2000) Significance of multiple mutations in cancer. Carcinogenesis 21: 379-385.
11. Strong LC (1945) A genetic analysis of the induction of tumours by methyl- cholanthrene: XI. Germinal mutations and other sudden biological changes following subcutaneous injection of methylcholanthrene. Proc. Natl. Acad. Sci. USA 31: 290-293.
12. Burdette WJ (1955) The significance of mutation in relation to the origin of tumours: a review. Cancer Res. 15: 201-226.
13. Brookes P and Lawley PD (1964) Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of the hydrocarbons and their binding to deoxyribonucleic acid. Nature 202: 781-784.
14. Miller EC and Miller JA (1966) Mechanism of chemical carcinogenesis: nature of proximate carcinogens and interaction with macromolecules. Pharmacol. Rev. 18: 805-838.
15. Mailing HV (1971) Dimethylnitrosamine: formation of mutagenic compounds by interaction with mouse liver microsomes. Mutat. Res. 13: 425429.
16. Ames BN, Sims P and Grover PL (1972) Epoxides of carcinogenic polycyclic hydrocarbons are frameshift mutagens. Science 176: 47-49.
17. Ames BN, Durston WE, Yamasaki E and Lee FD (1973) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. USA 70: 2281-2285.
18. McCann J, Springam NE, Kobori J and Ames BN (1975) Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids. Proc. Natl. Acad. Sci. USA 72: 979-983.
19. Tarmy EM, Venitt S and Brookes P (1973) Mutagenicity of the carcinogen 7-bromomethylbenz[a]anthracene: a quantitative study in repair-deficient strains of Escherichia coli. Mutat. Res. 19: 153-166.
20. Ivanovic V and Weinstein IB (1980) Genetic factors in Escherichia coli that affect cell killing and mutagenesis induced by benzo[a]pyrene-7,8- dihydrodiol-9,10-oxide. Cancer Res. 40: 3508-3511.
21. Glatt HR, Staffa-Piée A, Enders N, Baidossi W and Blum J (1994) The presence of KC1 in the exposure medium strongly influences the mutagenicity of metabolites of polycyclic aromatic hydrocarbons in Escherichia coli. Mutat. Res. 324: 111-114.
22. McCann J, Choi E, Yamasaki E and Ames BN (1975) Detection of carcinogens as mutagens in the Salmonella/micmsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. USA 72: 5135-5139.
23. Coombs MM, Dixon C and Kissonerghis AM (1976) Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames’s test. Cancer Res. 36: 4525-4529.
24. Andrews AW, Thibault LH and Lijinsky W (1978) The relationship between carcinogenicity and mutagenicity of some polynuclear hydrocarbons. Mutat. Res. 51: 311-318.
25. Gold A, Nesnow S, Moore M, Garland H, Curtis G, Howard B, Graham D and Eisenstadt E (1980) Mutagenesis and morphological transformation of mammalian cells by a non-bay-region polycyclic cyclopenta[c,d]pyrene and its 3,4-oxide. Cancer Res. 40: 4482-4484.
26. Inbasekaran M, Witiak DT, Barone K and Loper JC (1980) Synthesis and mutagenicity of A-ring reduced analogues of 7,12-dimethylbenz[a]- anthracene. J. Med. Chem. 23: 278-281.
27. Takahashi Y, Nagao M, Sugimura T, Todo E and Murata I (1980) Mutagenicities of new non-alternant isomers of benzo[a]pyrene. Mutat. Res. 78: 295-299.
28. Malaveille C, Hautefeuille A, Bartsch H, MacNicoll AD, Grover PL and SimsP (1980) Liver microsome-mediated mutagenicity of dihydrodiols derived from dibenz [a, cl anthracene in S. typhimurium TAIOO. Carcinogenesis 1: 287-289.
29. Oesch F, Bücker M and Glatt HR (1981) Activation of phenanthrene to mutagenic metabolites and evidence for at least two different activation pathways. Mutat. Res. 81: 1-10.
30. LaVoie EJ, Tulley-Freiler L, Bedenko V and Hoffmann D (1981) Mutagenicity, tumor-initiating activity, and metabolism of methylphenanthrenes. Cancer Res. 41: 3441-3447.
31. LaVoie EJ, Tulley L, Bedenko V and Hoffmann D (1981) Mutagenicity of methylated fluorenes and benzofluorenes. Mutat. Res. 91: 167-176.
32. LaVoie EJ, Tulley-Freiler L, Bedenko V and Hoffmann D (1983) Mutagenicity of substituted phenanthrenes in Salmonella typhimurium. Mutat. Res. 116: 91-102.
33. Sangaiah R, Gold A, Toney GE, Toney SH, Claxton L, Easterling R and Nesnow S (1983) Benz[J]aceanthrylene: a novel polycyclic aromatic hydrocarbon with bacterial mutagenic activity. Mutat. Res. 119: 259-266.
34. LaVoie EJ, Coleman DT, Tonne RL and Hoffmann D (1983) Mutagenicity, tumor-initiating activity, and metabolism of methylated anthracenes. In: Polynuclear Aromatic Hydrocarbons: Formation, Metabolism and Measurement [Cooke M and Dennis AJ (eds.)] pp 785-798, Battelle Press, Columbus, OH, USA.
35. Nesnow S, Leavitt S, Easterling R, Watts R, Toney SH, Claxton L, Sangaiah R, Toney GE, Wiley J, Fraher P and Gold A (1984) Mutagenicity of cyclopenta-fused isomers of benz[a]anthracene in bacterial and rodent cells and identification of the major rat liver microsomal metabolites. Cancer Res. 44: 4993-5003.
36. Kohan MJ, Sangaiah R, Ball LM and Gold A (1985) Bacterial mutagenicity of aceanthrylene: a novel cyclopenta-fused polycyclic aromatic hydrocarbon of low molecular weight. Mutat. Res. 155: 95-98.
37. Utesch D, Glatt HR and Oesch F (1987) Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenicity of benz[a]anthracene, benzo[a]pyrene and twenty-five methylated derivatives. Cancer Res. 47: 1509-1515.
38. Rice JE, Geddie NG, DeFloria MC and LaVoie EJ (1988) Structural requirements favoring mutagenic activity among methylated pyrenes in S. typhimurium. In: Polynuclear Aromatic Hydrocarbons: A Decade of Progress [Cooke M and Dennis AJ (eds.)] pp 773-785, Battelle Press, Columbus, OH, USA.
39. Seidel A, Glatt HR, Oesch F and Garrigues P (1990) 2,6-Dimethylpicene: synthesis, mutagenic activity, and identification in natural samples. Polycycl. Aromat. Compds. 1: 3-14.
40. Devanesan PD, Cremonesi P, Nunnaüy JE, Rogan EG and Cavalieri EL (1990) Metabolism and mutagenicity of dibenzo[a,e]pyrene and the very potent environmental carcinogen dibenzo[a,l]pyrene. Chem. Res. Toxicol. 3: 580-586.
41. Cheung YL, Gray TJB and Ioannides C (1993) Mutagenicity of chrysene, its methyl and benzo derivatives, and their interactions with cytochromes P450 and theAh-receptor: relevance to their carcinogenic potency. Toxicology 81: 69-86.
42. Mersch-Sundermann V, Schneider U, Klopman G and Rosenkranz HS (1994) SOS induction in Escherichia coli and Salmonella mutagenicity: a comparison using 330 compounds. Mutagenesis 9: 205-224.
43. Gibson TL, Smart VB and Smitz LL (1978) Non-enzymic activation of polycyclic aromatic hydrocarbons as mutagens. Mutat. Res. 49: 153-161.
44. Glatt HR, Schwind H, Zajdela F, Croisy A, Jacquignon PC and Oesch F (1979) Mutagenicity of 43 structurally related heterocyclic compounds and its relationship to their carcinogenicity. Mutat. Res. 66: 307-328.
45. Okuda H, Kitahara Y, Shudo K and Okamoto T (1979) Identification of an ultimate mutagen of 10-azabenzo[a]pyrene. Chem. Pharm. Bull. 27:2547-2549.
46. LaVoie EJ, Briggs G, Bedenko V and Hoffmann D (1982) Mutagenicity of substituted carbazoles in Salmonella typhimurium. Mutat. Res. 101: 141-150.
47. Adams EA, LaVoie EJ and Hoffmann D (1983) Mutagenicity and metabolism of azaphenanthrenes. In: Polynuclear Aromatic Hydrocarbons: Formation, Metabolism and Measurement [Cooke M and Dennis AJ (eds.)] pp 73-87, Battelle Press, Columbus, OH, USA.
48. Quillardet P, Jenek J, Demerseman P, Royer R and Hofnung M (1986) Genotoxic activity of two furan analogues of benzo[a]pyrene and their 2-nitro derivatives. Mutat. Res. 172: 223-230.
49. Glatt HR, Billings R, Platt KL and Oesch F (1981) Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo[a]pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate. Cancer Res. 41: 270-277.
50. Tu MH, Perry D and Chen C (1979) Mutagenic effect of 7,12-dimethyl- benz[a]anthracene-epidioxide on Salmonella typhimurium. Mol. Pharmacol. 15: 189-191.
51. Issaq HD, Andrews AW, Janini GM and Barr EW (1979) Isolation of stable mutagenic photodecomposition products of benzo[a]pyrene by thin-layer chromatography. J. Liquid Chromat. 2: 319-325.
52. Selby CP, Calkins J, Enoch HG, Wright CW and Wilson BW (1987) Chemical basis for photomutagenicity in synthetic fuels and correlation with carcinogenicity. Mutat. Res. 188: 287-299.
53. Glatt HR and Oesch F (1986) Structural and metabolic parameters governing the mutagenicity of polycyclic aromatic hydrocarbons. In: Chemical Mutagens: Principles and Methods for Their Detection [De Serres FJ (ed.)] Volume 10, pp 73-127, Plenum Press, New York.
54. Irwin SE, Kwei GY, Blackburn GR, Thurman R and Kauffman FC (1992) Mutagenicity of benzo[a]pyrenyl-1 -sulfate in the Ames test. Environ. Mol. Mutagen. 19: 253-258.
55. Green JL and Reed GA (1990) Benzo[a]pyrene bay-region sulfonates, a novel class of reactive intermediates. Chem. Res. Toxicol. 3: 59-64.
56. Flowers-Geary L, Bleczinski W, Harvey RG and Penning TM (1996) Cytotoxicity and mutagenicity of polycyclic aromatic hydrocarbon o-quinones produced by dihydrodiol dehydrogenase. Chem.-Biol. Interact. 99: 55-72.
57. Thakker DR, Yagi H, Levin W, Wood AW, Conney AH and Jerina DM (1985) Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. In: Bioactivation of Foreign Compounds [Anders MW (ed.)] pp 177-242, Academic Press, London.
58. Glatt HR, Piée A, Pauly K, Steinbrecher T, Schrode R, Oesch F and Seidel A (1991) Fjord- and bay-region diol-epoxides investigated on stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells. Cancer Res. 51: 1659-1667.
59. Luch A, Glatt HR, Platt KL, Oesch F and Seidel A (1994) Synthesis and mutagenicity of the diastereomeric fjord-region 11,12-dihydrodiol 13,14- epoxides of dibenzo[a,l]pyrene. Carcinogenesis 15: 2507-2516.
60. Glatt HR, Martiné U, Baidossi W and Blum J (1991) Strong influence of the exposure medium on mutagenicity in the Ames test: 7-methylbenz[a]- anthracene-5,6-oxide. Mutagenesis 6: 537-540.
61. Glatt HR, Friedberg T, Grover PL, Sims P and Oesch F (1983) Inactivation of a diol-epoxide and a K-region epoxide with high efficiency by glutathione transferase X. Cancer Res. 43: 5713-5717.
62. Glatt HR, Cooper CS, Grover PL, Sims P, Bentley P, Merdes M, Waechter F, Vogel K, Guenthner TM and Oesch F (1982) Inactivation of a diol-epoxide by dihydrodiol dehydrogenase, but not by two epoxide hydrolases. Science 215: 1507-1509.
63. Enders N, Seidel A, Monnerjahn S and Glatt HR (1993) Synthesis of 11 benzylic sulfate esters, their bacterial mutagenicity and its modulation by chloride, bromide and acetate anions. Polycycl. Aromat. Compds. 3: 887s-894s.
64. Glatt HR, Bartsch I, Doehmer J and Werle-Schneider G (1996) External versus internal metabolic activation of polycyclic aromatic compounds in mutagenicity tests: a comparison using heterologous expression systems. Polycycl. Aromat. Compds. 10: 43-50.
65. Landsiedel R, Engst W, Seidel A and Glatt HR (1996) Physico-chemical properties and mutagenicity of benzylic compounds. Exp. Toxicol. Pathol. 48, Suppl 2: 215-222.
66. Glatt HR (2000) Sulfotransferases in the bioactivation of xenobiotics. Chem.-Biol. Interact. 129: 141-170.
67. Casale GP, Singhal M, Bhattacharya SK, RamaNathan R, Roberts KP, Barbacci DC, Zhao J, Jankowiak R, Gross ML, Cavalieri EL, Small GJ, Rennard SI, Mumford JL and Shen M (2001) Detection and quantification of depurinated benzo[a]pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke. Chem. Res. Toxicol. 14: 192-201.
68. Cavalieri EL and Rogan EG (1995) Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 25: 677-688.
69. Ludewig G, Dogra S, Setiabudi F, Seidel A, Oesch F and Glatt HR (1991) Quinones derived from polycyclic aromatic hydrocarbons: induction of diverse mutagenic and genotoxic effects in mammalian cells. In: Polynuclear Aromatic Hydrocarbons: Measurements, Means, and Metabolism [Cooke M, Loening K, and Merritt J (eds.)] pp 545-556, Battelle Press, Columbus, OH, USA.
70. Chesis PL, Levin DE, Smith MT, Emster L and Ames BN (1984) Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc. Natl. Acad. Sci. USA 81: 1696-1700.
71. Kranendonk M, Carreira F, Theisen P, Laires A, Fisher CW, Rueff J, Estabrook RW and Vermeulen NPE (1999) Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies. Mutat. Res. 441: 73-83.
72. Josephy PD, Batty SM and Boverhof DR (2001) Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains. Environ. Mol. Mutagen. 38:12-18.
73. Kamataki T and Fujita K (2002) Mutagenesis testing based on bacterial expression of human P450s. Methods Enzymol. 357: 301-310.
74. Xu J, Whong WZ and Ong T (1984) Validation of the Salmonella (SV50)/ arabinose-resistant forward mutation assay system with 26 compounds. Mutat. Res. 130: 79-86.
75. De Cameri I, Castellino S, Lorenzetti R, Ravenna L and Rivolta R (1980) Quantitative forward mutation to 8-azaguanine resistance and reverse mutation to histidine independence induced in Salmonella typhimurium by metabolically activated chemicals. Microbiologica 3: 1-14.
76. Penman BW, Kaden DA, Liber HL, Skopek TR and Thilly WG (1980) Perylene is a more potent mutagen than benzo[a]pyrene for S. typhimurium. Mutat. Res. 77: 271-277.
77. Skopek TR and Thilly WG (1983) Rate of induced forward mutation at 3 genetic loci in Salmonella typhimurium. Mutat. Res. 108: 45-56.
78. Mersch-Sundermann V, Rosenkranz HS and Klopman G (1992) Structural basis of the genotoxicity of polycyclic aromatic hydrocarbons. Mutagenesis 7:211-218.
79. Shimada T, Oda Y, Gillam EMJ, Guengerich FP and Inoue K (2001) Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P4501B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab. Disp. 29: 1176-1182.
80. Aryal P, Terashita T, Guengerich FP, Shimada T and Oda Y (2000) Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial 0-acetyltransferase in SOS/umu assay. Environ. Mol. Mutagen. 36: 121-126.
81. Legator MS, Bueding E, Batzinger R, Connor TH, Eisenstadt E, Farrow MG, Ficsor G, Hsie A, Seed J and Stafford RS (1982) An evaluation of the host- mediated assay and body fluid analysis: a report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 98: 319-374.
82. Simmon VF, Rosenkranz HS, Zeiger E and Poirier LA (1979) Mutagenic activity of chemical carcinogens and related compounds in the intraperitoneal host-mediated assay. J. Natl. Cancer Inst. 62: 911-918.
83. Batzinger RP, Ou SYL and Bueding E (1978) Antimutagenic effects of 2(3)-trans-butyl-4-hydroxyanisole and of antimicrobial agents. Cancer Res. 38; 4478-4485.
84. Glatt HR, Bücker M, Platt KL and Oesch F (1985) Host-mediated mutagenicity experiments with benzo[a] pyrene and two of its metabolites. Mutat. Res. 156: 163-169.
85. Glatt HR (1994) Comparison of common gene mutation tests in mammalian cells in culture: a position paper of the GUM Commission for the Development of Guidelines for Genotoxicity Testing. Mutat. Res. 313: 7-20.
86. Huberman E, Aspiras L, Heidelberger C, Grover PL and Sims P (1971) Mutagenicity to mammalian cells of epoxides and other derivatives of polycyclic hydrocarbons. Proc. Natl. Acad. Sci. USA 68: 3195-3199.
87. Huberman E and Sachs L (1976) Mutability of different genetic loci in mammalian cells by metabolically activated carcinogenic polycyclic hydrocarbons. Proc. Natl. Acad. Sci. USA 73: 188-192.
88. Krahn DF and Heidelberger C (1977) Liver homogenate-mediated mutagenesis in Chinese hamster Y79 cells by polycyclic aromatic hydrocarbons and aflatoxins. Mutat. Res. 46: 27-44.
89. Dogra S, Doehmer J, Glatt HR, Mölders R, Siegert P, Friedberg T, Seidel A and Oesch F (1990) Stable expression of rat cytochrome P450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing. Mol. Pharmacol. 37: 608-613.
90. Glatt HR, Pudil J, Seidel A and Czich A (1994) Stable expression of heterologous sulfotransferase in V79 cells: activation of primary and secondary benzylic alcohols. Polycycl. Aromat. Compds. 7: 153-160.
91. Czich A, Bartsch I, Dogra S, Homhardt S and Glatt HR (1994) Stable heterologous expression of hydroxysteroid sulphotransferase in Chinese hamster V79 cells and their use for toxicological investigations. Chem.-Biol. Interact. 92: 119-128.
92. Glatt HR, Pabel U, Muckel E and Meinl W (2002) Activation of polycyclic aromatic compounds by cDNA-expressed phase I and phase II enzymes. Polycycl. Aromat. Compds. 22: 955-967.
93. Teubner W, Meinl W and Glatt HR (2002) Stable expression of rat sulfotransferase 1B1 in V79 cells: activation of benzylic alcohols to mutagens. Carcinogenesis 23: 1877-1884.
94. Wislocki PG, Wood AW, Chang RL, Levin W, Yagi H, Hernandez O, Dansette PM, Jerina DM and Conney AH (1976) Mutagenicity and cytotoxicity of benzo[a]pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells. Cancer Res. 36: 3350-3357.
95. Huberman E, Sachs L, Yang SK and Gelboin V (1976) Identification of mutagenic metabolites of benzo[a]pyrene in mammalian cells. Proc. Natl. Acad. Sci. USA 73: 607-611.
96. Newbold RF and Brookes P (1976) Exceptional mutagenicity of a benzo- [a]pyrene diol epoxide in cultured mammalian cells. Nature 261: 52-54.
97. Chang RL, Wood AW, Levin W, Mah HD, Thakker DR, Jerina DM and Conney AH (1979) Differences in mutagenicity and cytotoxicity of (+)- and (-)-benzo[a]pyrene 4,5-oxide: a synergic interaction of enantiomers. Proc. Natl. Acad. Sci. USA 76: 4280-4284.
98. Glatt HR, Seidel A, Bochnitschek A, Marquardt H, Hodgson RM, Grover PL and Oesch F (1986) Mutagenic and cell-transforming activities of triol- epoxides as compared to other chrysene metabolites. Cancer Res. 46: 4556-4565.
99. Glatt HR, Gemperlein I, Setiabudi F, Platt KL and Oesch F (1990) Expression of xenobiotic-metabolising enzymes in propagatable cell cultures and induction of micronuclei by 13 compounds. Mutagenesis 5: 241-249.
100. Glatt HR, Ludewig G, Platt KL, Waechter F, Yona I, Ben-Shoshan S, Jerushalmy P, Blum J and Oesch F (1985) Arene imines, a new class of exceptionally potent mutagens in bacterial and mammalian cells. Cancer Res. 45: 2600-2607.
101. Seidel A, Friedberg T, Löllmann B, Schwierzok A, Funk M, Frank H, Holler R, Oesch F and Glatt HR (1998) Detoxification of optically active bay- and fjord-region polycyclic aromatic hydrocarbon dihydrodiol epoxides by human glutathione transferase P1-1 expressed in Chinese hamster V79 cells. Carcinogenesis 19: 1975-1981.
102. Sundberg K, Dreij K, Bemtsen S, Seidel A and Jemström B (2001) Expression of human glutathione transferases in V79 cells and the effect on DNA adduct-formation of diol epoxides derived from polycyclic aromatic hydrocarbons. Chem.-Biol. Interact. 133: 91-94.
103. Pal K, Grover PL and Sims P (1980) The induction of sister-chromatid exchanges in Chinese hamster ovary cells by some epoxides and phenolic derivatives of benzo[a]pyrene. Mutat. Res. 78: 193-199.
104. Pal K (1981) The induction of sister-chromatid exchanges in Chinese hamster ovary cells by K-region epoxides and some dihydrodiols derived frombenz[a]anthracene, dibenz[a,c]anthracene and dibenz[a,h]anthracene. Mutat. Res. 84: 389-398.
105. Glatt HR, Bartsch I, Christoph S, Coughtrie MWH, Falany CN, Hagen M, Landsiedel R, Pabel XJ, Phillips DH, Seidel A and Yamazoe Y (1998) Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems. Chem.-Biol. Interact. 109: 195-219.
106. Rudiger HW, Harder W, Maack P, Kohl FV and Schmidt-Preuss U (1981) Decreased rate of benzo[a]pyrene-induced sister chromatid exchange in fibroblast cultures from patients with lung cancer. J. Cancer Res. Clin. Oncol. 102: 169-175.
107. Salama SA, Sierra-Torres CH, Oh HY, Hamada FA and Au WW (2001) Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene. Environ. Mol. Mutagen. 37: 17-26.
108. Rice JE, Rivenson A, Braley J and LaVoie EJ (1987) Methylated derivatives of pyrene and fluorene: evaluation of genotoxicity in the hepatocyte/DNA repair test and tumorigenic activity in newborn mice. J. Toxicol. Environ. Health 21: 525-532.
109. Andrae U, Kreis P, Coughtrie MWH, Pabel U, Meinl W, Bartsch I and Glatt HR (1999) Activation of propane 2-nitronate to a genotoxicant in V79- derived cell lines engineered for the expression of rat hepatic sulfotrans- ferases. Mutat. Res. 439: 191-197.
110. Kreis P, Brandner S, Coughtrie MWH, Pabel U, Meinl W, Glatt HR and Andrae U (2000) Human phenol sulfotransferases hP-PST and hM-PST activate propane 2-nitronate to a genotoxicant. Carcinogenesis 21: 295-299.
111. Lavi S and Etkin S (1981) Carcinogen-mediated induction of SV40 DNA synthesis in SV40 transformed Chinese hamster embryo cells. Carcinogenesis 2: 417-423.
112. Raj AS and Katz M (1983) Inhibitory effect of 7,8-benzoflavone on DMBA- and BaP-induced bone marrow micronuclei in mouse. Mutat. Res. 110: 337-342.
113. Shimada H, Suzuki H, Itoh S, Hattori C, Matsuura Y, Tada S and Watanabe C (1992) The micronucleus test of benzo[a]pyrene with mouse and rat peripheral blood reticulocytes. Mutat. Res. 278: 165-168.
114. Suzuki T, Tamai K, Kodama Y, Asita AO, Matsuoka A, Sofuni T, Kurita M, Ohtsuki H, Hiwatashi T and Hayashi M (1992) Micronucleus induction in mouse peripheral reticulocytes by 7,12-dimethylbenz[a]anthracene. Mutat. Res. 278: 169-173.
115. Glatt HR, Seidel A, Oesch F and Gumbsch A (1994) Fjord-region diol- epoxides of benzo[c] chrysene are potent inducers of micronuclei in murine bone marrow. Mutat. Res. 309: 37-43.
116. He SL and Baker R (1991) Micronuclei in mouse skin cells following in vivo exposure to benzo[a]pyrene, 7,12-dimethylbenz[a]anthracene, chrysene, pyrene and urethane. Environ. Mol. Mutagen. 17: 163-168.
117. Baker RSU, Bonin AM, Arlauskas A, He S and Coombs MM (1992) Tumorigenicity of cyclopenta[a]phenanthrene derivatives and micronucleus induction in mouse skin. Carcinogenesis 13: 329-332.
118. Cole RJ, Cole J, Henderson L, Taylor NA, Arlett CF and Regan T (1983) Short-term tests for transplacentally active carcinogens: a comparison of sister-chromatid exchange and the micronucleus test in mouse foetal liver erythroblasts. Mutat. Res. 113: 61-75.
119. Müller L (1988) Micronucleus induction in mouse and rat fetuses treated transplacentally during histogenesis with mitomycin C and 7,12- dimethylbenz[a]anthracene. Teratog. Carcinog. Mutagen. 8: 303-313.
120. Wang MY and Lu LJ (1990) Differential effect of gestation stage on benzo[a]pyrene-induced micronucleus formation and/or covalent DNA modifications in mice. Cancer Res. 50: 2146-2151.
121. Bol SA, van Steeg H, Jansen JG, van Oostrom C, de Vries A, de Groot AJ, Tates AD, Vrieling H, van Zeeland AA and Mullenders LH (1998) Elevated frequencies of benzo[a]pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice. Cancer Res. 58: 2850-2856.
122. Wijnhoven SWP, Kool HJM, van Oostrom CTM, Beems RB, Mullenders LHF, van Zeeland AA, van der Horst GTJ, Vrieling H and van Steeg H (2000) The relationship between benzo [a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice. Cancer Res. 60: 5681-5687.
123. Maier P, Manser P and Zbinden G (1980) Granuloma pouch assay: induction of 6-thioguanine resistance by MNNG and benzo[a]pyrene in vivo. Mutat. Res. 77: 165-173.
124. Russell LB, Selby PB, von Halle E, Sheridan W and Valcovic L (1981) Use of the mouse spot test in chemical mutagenesis: interpretation of past data and recommendations for future work. Mutat. Res. 86: 355-379.
125. Hakura A, Tsutsui Y, Sonoda J, Kai JK, Imade T, Shimada M, Sugihara Y and Mikami T (1998) Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta™Mouse). Mutat. Res. 398: 123-130.
126. Dean SW, Coates A, Brooks TM and Burlinson B (1998) Benzo[a]pyrene site of contact mutagenicity in skin of Muta™ mouse. Mutagenesis 13:515-518.
127. Miller ML, Vasunia K, Talaska G Andringa A, de Boer J and Dixon K (2000) The tumor promoter TPA enhances benzo[a]pyrene and benzo[a]pyrene diol- epoxide mutagenesis in Big Blue mouse skin. Environ. Mol. Mutagen. 35: 319-327.
128. Bayer U and Bauknecht T (1977) The dose-dependence of sister chromatid exchanges induced by 3 hydrocarbons, in the in vivo bone marrow test with Chinese hamsters. Experientia 33: 25.
129. Roszinsky-Köcher G, Basler A and Röhrbom G (1979) Mutagenicity of polycyclic hydrocarbons: V. Induction of sister-chromatid exchanges in vivo. Mutat. Res. 66: 65-67.
130. Schreck RR and Latt SA (1980) Comparison of benzo[a]pyrene metabolism and sister chromatid exchange induction in mice. Nature 288: 407-408.
131. Tice RR, Ivett JL and McFee AF (1987) The effect of agent treatment time on the induction of sister-chromatid exchanges in mouse bone marrow cells in vivo. Mutat. Res. 182: 15-29.
132. Sirianni SR and Huang CC (1978) Sister chromatid exchange induced by promutagens/carcinogens in Chinese hamster cells cultured in diffusion chambers in mice. Proc. Soc. Exp. Biol. Med. 158: 269-274.
133. Galloway SM, Perry PE, Meneses J, Nebert DW and Pedersen RA (1980) Cultured mouse embryos metabolize benzo[a]pyrene during early gestation: genetic differences detectable by sister chromatid exchange. Proc. Natl. Acad. Sci. USA 77: 3524-3528.
134. Murota T, Shibuya T and Iwahara S (1981) Dominant lethal testing of 7,12- dimethylbenz[a]anthracene with spermatogenic cells of mice. Mutat. Res. 91: 273-277.
135. Generoso WM, Cain KT, Hellwig CS and Cacheiro NLA (1982) Lack of association between induction of dominant-lethal mutations and induction of heritable translocations with benzo[a]pyrene in postmeiotic germ cells of male mice. Mutat. Res. 94: 155-163.
136. Schiltz M, Cui XX, Lu YP, Yagi H, Jerina DM, Zdzienicka MZ, Chang RL, Conney AH and Wei SJC (1999) Characterization of the mutational profile of (+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydro- benzo[a]pyrene at the hypoxanthine (guanine) phosphoribosyltransferase gene in repair-deficient Chinese hamster V-H1 cells. Carcinogenesis 20: 2279-2285.
137. Hakura A, Tsutsui Y, Sonoda J, Tsukidate K, Mikami T and Sagami F (2000) Comparison of the mutational spectra of the lacZ transgene in four organs of the Muta™ mouse treated with benzo[a]pyrene: target organ specificity. Mutat. Res. 447: 239-247.
138. Bizub D, Wood AW and Skalka AM (1986) Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc. Natl. Acad. Sci. USA 83: 6048-6052.
139. Ruggeri B, Dirado M, Zhang SY, Bauer B, Goodrow T and Kleinszanto AJP (1993) Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G-to-T mutations in the p53-gene. Proc. Natl. Acad. Sci. USA 90: 1013-1017.
140. Wang DA, You L, Sneddon J, Cheng SJ, Jamasbi R and Stoner GD (1995) Frameshift mutation in codon 176 of the p53 gene in rat esophageal epithelial rells transformed by benzo[a]pyrene dihydrodiol. Mol. Carcinog. 14: 84-93.
141. Cherpillod P and Amstad PA (1995) Benzo[a]pyrene-induced mutagenesis of p53 hot-spot codons 248 and 249 in human hepatocytes. Mol. Carcinog. 13: 15-20.
142. Puisieux A, Lim S, Groopman J and Ozturk M (1991) Selective targeting of p53 gene mutational hotspots in human cancer by etiologically defined carcinogens. Cancer Res. 51: 6185-6189.
143. Krawczak M and Cooper DN (1998) P53 mutations, benzo[a]pyrene and lung cancer. Mutagenesis 13: 319-320.
144. Yang JL, Maher VM and McCormick JJ (1987) Kinds of mutations formed when a shuttle vector containing adducts of benzo[a]pyrene-7,8-diol-9,10- epoxide replicates in COS7 cells. Mol. Cell Biol. 7: 1267-170.
145. Roilides E, Gielen JE, Tuteja N, Levine AS and Dixon K (1988) Mutational specificity of benzo[a]pyrene diolepoxide in monkey cells. Mutat. Res. 198: 199-206.
146. Gill RD, Rodriguez H, Cortez C, Harvey RG, Loechler EL and DiGiovanni J (1993) Mutagenic specificity of the (+)anti-diol epoxide of dibenz[a, j]anthracene in the supF gene of an Escherichia coli plasmid. Mol. Carcinog. 8: 145-154.
147. 2-Gua adduct of the (+)-anti-benzo[a]pyrene diol epoxide is capable of inducing G → A and G → C, in addition to G → T, mutations. Biochemistry 34: 13545-13553.
148. Bigger CAH, Ponten I, Page JE and Dipple A (2000) Mutational spectra for polycyclic aromatic hydrocarbons in the supF target gene. Mutat. Res. 450: 75-93.
149. 2- dG adduct of (+)-anti-B [a]PDE shows a dramatically different mutagenic specificity (predominantly, G → A) in a 5′-CGT-3′ sequence context. Biochemistry 36: 10256-10261.
150. ; sequence context. Carcinogenesis 20: 261-268.
151. Ponten I, Kroth H, Sayer JM, Dipple A and Jerina DM (2001) Differences between the mutational consequences of replication of cis- and transopened benzo[a]pyrene 7,8-diol 9,10-epoxide-deoxyguanosine adducts in M13mp7L2 constructs. Chem. Res. Toxicol. 14: 720-726.
152. 2 -deoxy guanosine adducts derived from the highly carcinogenic fjord-region benzo[c]phenanthrene 3,4-diol 1,2-epoxides. Chem. Res. Toxicol. 15:1619-1626.
153. 2-deoxyguanosine adduct induces mutations at multiple sites in DNA. J. Biol. Chem. 278: 14940-14948.
154. Ma L, Kuhlow A and Glatt HR (2002) Ethanol enhances the activation of 1 -hydroxymethylpyrene to DNA adduct-forming species in the rat. Polycycl. Aromat. Compds. 22: 933-946.
155. Meinl W, Meerman JH and Glatt HR (2002) Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium. Pharmacogenetics 12: 677-689.
156. Phillips DH, Glatt HR, Seidel A, Bochnitschek W, Oesch F and Grover PL (1986) Mutagenic potential and DNA adducts formed by diol-epoxides, triol-epoxides and K-region epoxide of chrysene in mammalian cells. Carcinogenesis 7: 1739-1743.
157. Glatt HR, Harvey RG, Phillips DH, Hewer A and Grover PL (1989) Influence of the alkyl substituent on mutagenicity and covalent DNA-binding of bay-region diol-epoxides of 7-methyl- and 7-ethylbenz[a]anthracene in Salmonella and V79 Chinese hamster cells. Cancer Res. 49: 1778-1782.
158. Phillips DH, Hewer A, Seidel A, Steinbrecher T, Schrode R, Oesch F and Glatt HR (1991) Relationship between mutagenicity and DNA adduct formation in mammalian cells for fjord-region and bay-region diol-epoxides of polycyclic aromatic hydrocarbons. Chem.-Biol. Interact. 80: 177-186.
159. Glatt HR, Wameling C, Elsberg S, Thomas H, Marquardt H, Hewer A, Phillips DH, Oesch F and Seidel A (1993) Genotoxicity characteristics of reverse diol-epoxides of chrysene. Carcinogenesis 14: 11-19.